Teva Pharmaceutical Industries (NYSE:TEVA) updated its FY18 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $2.25-2.50 for the period, compared to the Thomson Reuters consensus estimate of $2.99. The company issued revenue guidance of $18.3-18.8 billion, compared to the consensus revenue estimate of $19.36 billion.
Several brokerages have issued reports on TEVA. Piper Jaffray Companies downgraded Teva Pharmaceutical Industries from a neutral rating to an underweight rating and set a $11.00 price target for the company. in a report on Friday. Gabelli downgraded Teva Pharmaceutical Industries from a buy rating to a hold rating and set a $19.00 price target for the company. in a report on Friday. Deutsche Bank set a $18.00 price objective on Teva Pharmaceutical Industries and gave the stock a hold rating in a research report on Friday. Oppenheimer reiterated a hold rating on shares of Teva Pharmaceutical Industries in a research report on Thursday. Finally, Maxim Group reiterated a hold rating on shares of Teva Pharmaceutical Industries in a research report on Thursday. Ten equities research analysts have rated the stock with a sell rating, seventeen have given a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of $21.15.
Teva Pharmaceutical Industries (NYSE:TEVA) opened at $18.61 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.96 and a quick ratio of 0.66. Teva Pharmaceutical Industries has a 12-month low of $10.85 and a 12-month high of $37.94. The company has a market capitalization of $19,300.00, a price-to-earnings ratio of -1.15, a P/E/G ratio of 1.35 and a beta of 0.59.
Teva Pharmaceutical Industries Company Profile
Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.
Receive News & Ratings for Teva Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.